期刊文献+

高效液相色谱法测定人血浆中匹伐他汀浓度 被引量:2

HPLC determination of pitavastatin in human plasma
原文传递
导出
摘要 目的:建立以高效液相色谱法测定匹伐他汀血药浓度的方法。方法:分析柱为岛津VP-ODS(250mm×4.6mm,5μm),流动相为乙腈-30mmol.L-1磷酸二氢钾缓冲盐溶液-三乙胺(醋酸调pH=4.0)(43∶57∶0.1),流速为1.0mL.min-1,检测波长为244nm。结果:匹伐他汀在0.832~106.5μg.L-1检测浓度范围内呈良好线性关系(r=0.9998),最低定量限为0.832μg.L-1。高、中、低3种浓度的日内和日间RSD<8%。结论:该方法操作简便、灵敏、准确,适用于临床匹伐他汀的血药浓度监测及其药动学研究。 Objective:To establish an HPLC method for determination of pitavastatin in human plasma. Methods:Analytical column was Shimadzu VP-ODS(250 mm×4.6 mm,5 μm).The mobile phase consisted of acetonitrile-30 mmol·L-1 potassium dihydrogen phosphate-triethylamine (adjusting to pH4.0 with acetic acid) (43:57:0.1) with a flow rate of 1.0 mL·min-1.The detection was performed at UV 244 nm. Results:The calibration curve was linear in the concentrations ranging from 0.832 to 106.5 μg·L-1(r=0.9998).The lower limit of qualification was 0.832 μg·L-1.The intra-day and inter-day RSD were less than 8%. Conclusion:The method is simple,sensitive,accurate and suitable for determination of pitavastatin in human plasma and pharmacokinetic study.
出处 《药物分析杂志》 CAS CSCD 北大核心 2009年第8期1270-1272,共3页 Chinese Journal of Pharmaceutical Analysis
关键词 匹伐他汀 高效液相色谱法 血药浓度 pitavastatin HPLC plasma drug concentration
  • 相关文献

参考文献4

  • 1何笑荣,邹定,姜文清,马捷,李金娥.降血脂新药匹伐他汀[J].中国新药杂志,2005,14(4):483-487. 被引量:31
  • 2Kojima J, Fujino H, Yosimura M, et al. Simultaneous determination of NK - 104 and its lactone in biological samples by column - switching high - performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl,1999 ,724( 1 ) :173.
  • 3Chung JY, Cho JY, Yu KS, et al. Effect of OATP1 B 1 ( SLCO1 B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers. Clin Pharmacol Ther,2005,78 (4) : 342.
  • 4Fujino H, Yamada I, Shimada S ,et al. Metabolic fate of pitavastatin,a new inhibitor of HMG - CoA reductase : human UDP - glucuronosyltransferase enzymes involved in lactonization. Xenobiotica, 2003,33 (1):27.

二级参考文献25

  • 1Kajinami K, Koizumi J, Ueda K, et al. Effects of NK- 104, a new hydroxymethyglutaryl-coenzyme reductase inhibitor,on low-density lipoprotein cholesterol in heterozygous familial hyperc holesterolemia. Hokuriku NK-104 study group[J].Am J Cardiol,2000,85(2) : 178 - 183.
  • 2Sone H, Takahashi A, Shimano H, et al. HMG-OoA reductase inhibitor decreases small dense low-density lipoprotein and remnanlike particle cholesterol in patients with type-2 diabetes[J ].Life Sci, 2002,71 (20) : 2403 - 2412.
  • 3Akiba T, Shibuta T, Amano Y, et al. Six-month repeated oral toxicity study of NK-104 in rats[J]. J Toxicol Sci, 1998,23(Suppl 5) :S713 - S720.
  • 4Akiba T, Shibuta T, Amano Y, et al. 28-day repeated oral toxicity study of a hypolipidemic agent, NK-104 in rats[J]. J Toxicol Sci,1998,23(Suppl 5) :S701-S711.
  • 5Suzuki M, lwasaki H, Fuj;kawa Y, et al. Synthesis and biological evalutions of quinoline-based HMG-CoA reductase inhibitors[J].Bioorg Med Chem ,2001,9(10) :2727-2743.
  • 6Morikawa S, Umetani M, Nakagawa S, et al. Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells[J] .J Atheroscler Thromb ,2000,7(3):138-144.
  • 7Ooyen C, Zecca A, Bersino AM, et al. NK-104, a potent 3-hydroxy-3methylglutaryl coenzyme A reductase inhibitor, decreases apolipoprotein B-100 secretion from HepG2 cells[J]. Atherosclerosis,1999,145(1) :87 - 95.
  • 8Kohno M, Shinomiya K, Abe S, et al. Inhibition of migration and proliferation of rat vascular smooth muscle cells by a new HMGCoA reductase inhibitor, pitavastatin [J]. Hypertens Res, 2002,25(2) :279-285.
  • 9Morikawa S,Takabe W, Mataki C, et al. The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells[J]. J Atherosccler Thromb ,2002,9(4) : 178 - 183.
  • 10Kitahara M, Kanaki T, Toyoda K, et al. NK 104, a newly developed HMG-CoA reductase inhibitor,suppresses neointimal thickening by inhibiting smooth muscle cell growth and fibronectin production in ballon-injured rabbit carotid artery[J].Jpn J Pharmacol, 1998,77(2) : 117 - 128.

共引文献30

同被引文献12

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部